Altimmune, Inc.
ALT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $337,106 | $315,318 | $377,739 | $513,791 |
| - Cash | $61,236 | $183,105 | $49,104 | $36,926 |
| + Debt | $0 | $15,849 | $1,587 | $1,681 |
| Enterprise Value | $275,870 | $148,062 | $330,222 | $478,546 |
| Revenue | $5 | $5 | $5 | $5 |
| % Growth | 0% | 0% | 0% | – |
| Gross Profit | -$14,955 | $5 | $5 | $5 |
| % Margin | -299,100% | 100% | 100% | 100% |
| EBITDA | -$18,492 | -$21,852 | -$20,226 | -$23,146 |
| % Margin | -369,840% | -437,040% | -404,520% | -462,920% |
| Net Income | -$19,014 | -$22,146 | -$19,575 | -$23,180 |
| % Margin | -380,280% | -442,920% | -391,500% | -463,600% |
| EPS Diluted | -0.21 | -0.27 | -0.26 | -0.33 |
| % Growth | 22.2% | -3.8% | 21.2% | – |
| Operating Cash Flow | -$11,897 | -$19,648 | -$16,840 | -$18,265 |
| Capital Expenditures | $0 | -$10 | $0 | $0 |
| Free Cash Flow | -$11,897 | -$19,658 | -$16,840 | -$18,265 |